REC-994
REC-994-201
Phase 2 small_molecule completed
Quick answer
REC-994 for Cerebral Cavernous Malformation is a Phase 2 program (small_molecule) at RECURSION PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RECURSION PHARMACEUTICALS, INC.
- Indication
- Cerebral Cavernous Malformation
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed